دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Editor's Choice – John Ingram June 2023
doi : 10.1093/bjd/ljad143
British Journal of Dermatology, Volume 188, Issue 6, June 2023, Pages i–ii
The important but difficult exercise of getting valid descriptive skin cancer data
Esther de Vries
doi : 10.1093/bjd/ljad065
Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
Bernd W.M. Arents
doi : 10.1093/bjd/ljad068
The skin of people experiencing homelessness: more (known) is less (neglected)
Olivier Chosidow, Aileen Y Chang
doi : 10.1093/bjd/ljad088
Safety and longevity of biological treatment in the setting of moderate-to-severe psoriasis: enhancing the body of evidence
Lynda Spelman
doi : 10.1093/bjd/ljad112
Joint contribution of MC1R and MITF alleles to melanoma risk in the age of polygenic risk scores
William Bruno
doi : 10.1093/bjd/ljad097
Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies
Anna M Trier, Brian S Kim
doi : 10.1093/bjd/ljac016
Atopic dermatitis across the life course
Katrina Abuabara, Sinéad M Langan
doi : 10.1093/bjd/ljac072
How we treat atopic dermatitis now and how that will change over the next 5 years
Carsten Flohr
doi : 10.1093/bjd/ljac116
Global epidemiology and disparities in atopic dermatitis
Anisa Mosam, Gail Todd
doi : 10.1093/bjd/ljad042
Trial of intravenous immunoglobulin in dermatomyositis: a critically appraised research paper
Rachita Pandya, Julianne Kleitsch, Victoria P Werth
doi : 10.1093/bjd/ljad044
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Andrew Blauvelt, Jacob P Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, Jonathan I Silverberg
doi : 10.1093/bjd/ljad022
Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial
Bruce Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G Langley, Richard B Warren, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle Paul
doi : 10.1093/bjd/ljad035
Association of homelessness and skin conditions: a Danish population-based cohort study
Sandra F Nilsson, Zarqa Ali, Thomas M Laursen, Jacob P Thyssen, Alexander Egeberg, Merete Nordentoft, Carsten Hjorthøj, Simon F Thomsen
doi : 10.1093/bjd/ljad040
The MC1R r allele does not increase melanoma risk in MITF E318K carriers
Courtney K Wallingford, Anastassia Demeshko, Asha Krishnankutty Krishnakripa, Darren J Smit, David L Duffy, Brigid Betz-Stablein, Annette Pflugfelder, Kasturee Jagirdar, Elizabeth Holland, Graham J Mann, Clare A Primiero, Tatiane Yanes, Josep Malvehy, Cèlia Badenas, Cristina Carrera, Paula Aguilera, Catherine M Olsen, Sarah V Ward, Nikolas K Haass, Richard A Sturm, Susana Puig, David C Whiteman, Matthew H Law, Anne E Cust, Miriam Potrony, H Peter Soyer, Aideen M McInerney-Leo
doi : 10.1093/bjd/ljad041
‘Get Data Out’ Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013–2019 in England
Birgitta van Bodegraven, Sally Vernon, Charlotte Eversfield, Ruth Board, Paul Craig, Sonia Gran, Catherine A Harwood, Stephen Keohane, Nick J Levell, Rubeta N Matin, Charlotte Proby, Neil Rajan, Brian Rous, Anna Ascott, George W M Millington, Zoe C Venables, the British Association of Dermatologists National Disease Registration Service Steering Committee
doi : 10.1093/bjd/ljad033
Deep palmar phenotyping in atopic eczema: patterns associated with filaggrin variants, disease severity and barrier function in a South Asian population
Bjorn R Thomas, Xiang Li Tan, Stefan Van Duijvenboden, Sarah C Hogan, Aaron J Hughes, Soha S Tawfik, Sasha Dhoat, Ravinder Atkar, Elizabeth J Robinson, Syedia R Rahman, Samiha Rahman, Rehana A Ahmed, Rubina Begum, Habiba Khanam, Emma L Bourne, Eva L Wozniak, Charles A Mein, David P Kelsell, Edel A O’Toole
doi : 10.1093/bjd/ljad036
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)
Alexander Egeberg, Jacob P Thyssen
doi : 10.1093/bjd/ljad039
The unbreakable journey: using photovoice to raise awareness and fight leprosy stigma in Papua, Indonesia
Ragil Dien, Hana Krismawati, Ivon Ayomi, Diana Timoria, Mary Chambers, Hardyanto Soebono, Marlous L Grijsen
doi : 10.1093/bjd/ljad059
The ethical implications of opportunistic detection of melanoma in clinical care
Catherine M Olsen, Louisa G Gordon, Stacy M Carter, David C Whiteman
doi : 10.1093/bjd/ljad055
Clinical features in adults with acquired cutis laxa: a retrospective review
Katie A O’Connell, Morgan Schaefer, Lihi Atzmony, Ruth Ann Vleugels, Keith Choate, Avery H LaChance, Michelle S Min
doi : 10.1093/bjd/ljad043
Neutropenia in patients on dupilumab for atopic dermatitis: a case series and review of trial data
Pirunthan Pathmarajah, Roberto Corso, Amr Salam, Gulnaz Shah, Richard Woolf, Catherine H Smith, Andrew E Pink
doi : 10.1093/bjd/ljad038
Statin use and risk of cutaneous melanoma: a nationwide nested case–control study
Reza Ghiasvand, Leon A M Berge, Bettina K Andreassen, Adele C Green, Marie Al Rahmoun, Agnès Fournier, Marina Kvaskoff, Marit B Veierød, Trude E Robsahm
doi : 10.1093/bjd/ljad057
Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project
Amit Garg, Sahil Rawal, Oleg Akilov, Afsaneh Alavi, Christine Ardon, Falk G Bechara, Arnon D Cohen, Steven R Cohen, Steven Daveluy, Véronique del Marmol, Maïa Delage, Solveig Esmann, Shani Fisher, Evangelos J Giamarellos-Bourboulis, Amelia Glowaczewska, Noah Goldfarb, Elena Gonzalez Brant, Øystein Grimstad, Sandra Guilbault, Iltefat Hamzavi, Rosalind Hughes, John R Ingram, Gregor B E Jemec, Qiang Ju, Naomi Kappe, Brian Kirby, Joslyn S Kirby, Michelle A Lowes, Lukasz Matusiak, Stella Micha, Robert G Micheletti, Angela P Miller, Dagfinn Moseng, Haley B Naik, Aude Nassif, Georgios Nikolakis, So Yeon Paek, Jose Carlos Pascual, Errol Prens, Barry Resnik, Hassan Riad, Christopher Sayed, Saxon D Smith, Yssra Soliman, Jacek C Szepietowski, Jerry Tan, Linnea Thorlacius, Thrasyvoulos Tzellos, Hessel H van der Zee, Bente Villumsen, Lanqi Wang, Christos C Zouboulis, Andrew Strunk
doi : 10.1093/bjd/ljad069
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial
Zoe D Draelos, David N Adam, H Chih-ho Hong, Mark G Lebwohl, Charles W Lynde, Walter K Nahm, Kim A Papp, David M Pariser, Linda Stein Gold, Daniel Stewart, Robert C Higham, David R Berk, David Krupa, Patrick Burnett
doi : 10.1093/bjd/ljad060
NanoString analysis of mycosis fungoides reveals individual molecular identity
Ruth Alonso-Alonso, Marta RodrÃguez, Nuria GarcÃa-DÃaz, Laura Tomás-Roca, Jennifer Borregón, Marta Cabezuelo-RodrÃguez, Marcos Rebollo-González, Luis Gallego-Manzano, Laura Cereceda, Socorro MarÃa Rodriguez-Pinilla, Raúl Córdoba, Juan Fernando GarcÃa, Juan Torre-Castro, Carmen M GarcÃa-Ã�lvarez, MarÃa del Mar Onteniente Gomis, Raquel Rivera-DÃaz, José Luis Rodriguez-Peralto, José Pedro Vaqué, Pablo Luis Ortiz-Romero, Miguel Ã� Piris
doi : 10.1093/bjd/ljad061
Risk of developing a second primary melanoma after a first primary melanoma in a population-based Australian cohort
Yuan Ni, Caroline G Watts, Richard A Scolyer, Christine Madronio, Bruce K Armstrong, Rachael L Morton, Scott W Menzies, Graham J Mann, John F Thompson, Serigne N Lo, Anne E Cust
doi : 10.1093/bjd/ljad076
Indeterminate cell histiocytosis treated with 0.5% delgocitinib ointment
Rai F T Fujimoto, Hiroyuki Miura, Mayumi Takata, Sakukei Fujiwara
doi : 10.1093/bjd/ljad029
Microblading-transmitted Monkeypox (mpox) infection: fomites matter
Juan Luis Castaño-Fernández, Mercè Grau-Pérez
doi : 10.1093/bjd/ljad063
Atopic dermatitis across the globe: differences in prevalence and access to treatments
doi : 10.1093/bjd/ljad145
Results from 1 year of treatment with lebrikizumab for atopic dermatitis
doi : 10.1093/bjd/ljad144
Atopic eczema: palmar patterns associated with filaggrin variants, disease severity and barrier function in a South Asian population
doi : 10.1093/bjd/ljad142
